About Us
Company Profile
Management Team
Team
Board of Directors
Scientific Advisors
Publications & Patents
Technologies
Antibody ID
Drug Conjugates
Cancer Stem Cell
Drug Discovery Pipeline
Services
Platform Technologies
Biomarker Discovery
Human Skin Equivalents
Drug Development Services
News
Contacts
Job Opportunities
About Us
Company Profile
Management Team
Team
Board of Directors
Scientific Advisors
Publications & Patents
Technologies
Antibody ID
Drug Conjugates
Cancer Stem Cell
Drug Discovery Pipeline
Services
Platform Technologies
Biomarker Discovery
Human Skin Equivalents
Drug Development Services
News
Contacts
Job Opportunities
Drug discovery pipeline 2
Drug discovery pipeline
FGFR4 project funded by:
Latest News
Exiris a Maker Faire Roma 2024
Interview with Paola Gallinari on “Osservatorio medico-scientifico”
Exiris @ RaiNews24
Exiris presents a “High Complexity-High Efficiency Human Antibody Phage Display Library” at the Festival of Biologics (FOB) 2019, Basel 15-17 October 2019
Exiris receives European Union research grant for the ETN MAGICBULLET RELOADED project
New data presented at the 35th European Peptide Symposium, 35EPS, Dublin 26th-31st August 2018
New data presented at the Peptides and Conjugates for Tumor Targeting, Therapy and Diagnosis, Riminipeptide2018 Congress
Exiris is awarded a grant from Regione Lazio LIFE 2020
Exiris files patent application on novel cancer therapeutic antibodies
New data presented at the 7th Annual World ADC Berlin 2017
© 2016 Exiris Srl · P.IVA 10897561006
